Frontotemporal dementia (FTD) is a group of neurodegenerative diseases including a wide
range of clinical phenotypes, neuropathological hallmarks, and genetic causes. People with …

The landscape of frontotemporal dementia (FTD) has evolved remarkably in recent years
and is barely recognizable from two decades ago. Knowledge of the clinical …

Approximately 20% of patients with the neurodegenerative disorder frontotemporal
dementia (FTD) have an autosomal dominant pattern of inheritance. Genetic FTD is caused …

Frontotemporal dementia (FTD) is one of the most common neurodegenerative diseases,
encompassing a myriad of different, clinically distinct subtypes which all target the …

Frontotemporal dementia (FTD) is a heterogeneous group of neurodegenerative disorders
that preferentially afflict the frontal and temporal lobes. The clinical presentation varies and …

Cerebrospinal fluid (CSF) or serum measures have so far shown limited utility as biomarkers
of disease onset or progression for disorders in the FTD spectrum. Serum progranulin …

Introduction The possibility to generalize our understandings on treatments and
assessments to both familial frontotemporal dementia (f‐FTD) and sporadic FTD (s‐FTD) is a …

Frontotemporal dementia (FTD) is a devastating neurodegenerative condition for which
there is currently no effective treatment. Although it is much less common than Alzheimer's …

Frontotemporal lobar degeneration (FTLD) represents a group of clinically,
neuropathologically and genetically heterogeneous disorders with plenty of overlaps …

Frontotemporal dementia (FTD) is a heterogenous neurodegenerative disease and is
caused by an autosomal dominant mutation in around one third of cases. This pattern of …